Successful expansion of CD34+ cord blood using UM171 for allogenic stem cell transplantation for cancer patients has been achieved in clinical settings (www.clinicaltrials.gov, accessed on 29 January 2016, NCT02668315). The gene discussed is CD34; the disease is cancer.